Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESTEEM testosterone trial in menopausal women on HRT
ISRCTN21554333Phase 3Recruiting
- Sponsor
- Cardiff University
- Start
- Nov 2026
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in menopause comparing AndroFeme plus standard HRT with Placebo plus standard HRT (2 arms). Primary endpoint: Primary: menopause-related quality of life. Started Nov 2026; status: recruiting.
02
Drugs
testosterone
03
Conditions
menopause
Beyond the preview
Go deeper on ISRCTN21554333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN21554333.